We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.14 | -6.86% | 1.90 | 1.84 | 1.96 | 2.01 | 2.00 | 2.00 | 1,925,128 | 16:35:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.76 | 6.7M |
Date | Subject | Author | Discuss |
---|---|---|---|
26/9/2018 12:20 | It's not about you being scared - it's an anonymous board hence its high troll count! As usual Nobby, you failed to answer the key part of the question that might portray you to be a duplicitous charlatan who is only interested in talking his own game so again... when did you invest? was it before or after Tim M became the chairman in March 2014? | watchman50 | |
26/9/2018 12:19 | Blockbuster potential this will reap rewards eventually | kirk 6 | |
26/9/2018 12:03 | NG - "Incanthera will be floating soon and I should make a healthy profit." Does that mean IMM will make a healthy profit on their £2Mil investment? | stockriser | |
26/9/2018 11:58 | LOL so you think your post stopped me posting. Oooh I was so scared.... Incanthera will be floating soon and I should make a healthy profit. I don’t let emotion get in the way of making money. | nobbygnome | |
26/9/2018 11:03 | See Nobby is back with a vengeance today, funny how he didn't have anything to say for days after my last post but the moment my question to him disappeared off the first page of comments he's back in like a shot.... watchman50 19 Sep '18 - 08:14 - 33543 of 33562 Edit Thought I would have a look in here to see if anything constructive is being said but not too surprised to see Nobby is still regularly posting his same troll like agenda. For a supposed man of science he does seem to behave very much like, and align himself with, many of the out and out trolls that seem to have this thread on their list of regular trolling outlets (worth checking out the obvious troll's posting histories as you will find nothing constructive across a whole variety of companies). Nobby, would suggest you take a long hard look at yourself in the mirror and ask yourself if there are any PLC's that would seriously want someone like yourself around their boardroom table. You must have been a dream to work with! Are you sure you retired voluntarily or were you nudged into taking early retirement by your company at their first opportunity in order to save the frustration of your colleagues during your descent from scientist to troll? With regard to your constant 'lying Tim' monologue I see the much respected SicilianKan tried to point out to you the difference between the role of a non-executive director and an executive director but strangely you didn't have much to say about that. I also note your response on the day of the corporate update (see bottom of this post). I would be very interested to hear how & when you made your investment in Incanthera and how you plan to sell your shares given that it is not publically listed and how you failed to notice your nemesis, Tim M, is the chairman (and EXECUTIVE board member) and has been since March 2014. --------- Nobbygnome - 07 Sep 2018 - 07:19:46 - 33281 of 33543 IMMUPHARMA - IN FINAL PHASE 3 LUPUS TRIAL TARGETING BLOCKBUSTER ($1bn+) REVENUES - IMM LOL. The phrase moving the deck chairs around on the Titanic comes to mind! Sadly I am a shareholder in Incanthera and do not want that company to have anything to do with the seriously flawed IMM. And as for giving Lupuzor away for 2 years well that also sums everything up. We can't sell it so let's give it away. Great corporate strategy guys..... Note there is no mention of a deal with another Pharma. I thought there was a queue out of the car park of companies eager to sign. And now strangely they have all disappeared. Che was trumpeting this until the cows came home and how completely wrong he was. So the shambles continues unabated. The management all deserve to go and as for McCarthy well the Incanthera deal proves I wouldn't trust him as far as I could kick him! Nobby -------------------- | watchman50 | |
26/9/2018 09:32 | Double post.. | nobbygnome | |
26/9/2018 09:32 | What great words of wisdom 🙄...... | nobbygnome | |
26/9/2018 09:16 | This is IMM things happen slooooower. Early bear trap. Enjoy. | dazah | |
26/9/2018 09:09 | Pray tell us why..... When you give me your words of wisdom then I will pile in! | nobbygnome | |
26/9/2018 09:05 | It's going up mate. You have no clue. | dazah | |
26/9/2018 08:47 | Going nowhere this one-Possibly down | bigsi2 | |
26/9/2018 08:35 | The funniest part of today's announcement is where Tim thanks the shareholders who supported the fund raising earlier in the year. Yes Tim you royally stuffed them and now their holding is worth less than10% of their original investment! I bet you can stop smiling about that one.... | nobbygnome | |
26/9/2018 07:57 | What a great short this was. RIP. | donald tramp | |
24/9/2018 09:28 | Share price erosion takes a while. It is slow and painful. It goes on and on, drip by drip, until nothing is left it its value. Sadly this will be the outcome and the story of a company led by charlatans. Sorry to say this to anyone hoping there will be light at the end of the tunnel. | fuji99 | |
22/9/2018 19:03 | TARGET ACQUISITION 21.75P DEATH 19 GONE DARK DEEP IN ENEMY TERRITORY TARGET 21.75P WILL BE NUKED | stealth mode | |
21/9/2018 23:35 | I am an independent lemming and don’t buy your rubbish dear Ken. | dopey47 | |
21/9/2018 16:11 | Todays rise is proof that: 1) Lemmings will buy any old rubbish. 2) Lemmings will buy any old rubbish. 3) Lemmings will buy any old rubbish. | ken chung | |
21/9/2018 11:46 | I may be wrong, but I'm sure Mr. McCarthy indicated there was going to be lots of news flow - Also, I suppose this is why we invested in Incanthera ....... -------------------- Why Invest Drug development has the potential to discover and develop the next ‘blockbuster&r Large pharmaceutical companies are increasingly licensing oncology products at earlier stages in the development cycle due to a dearth of opportunities from their own R & D efforts. The company will be seeking licensing partners at a point in the development cycle (e.g. Phase I clinical results), which maximises the return of investment to shareholders, whilst minimising the investment required. | stockriser | |
21/9/2018 11:26 | Have you seen the latest on Incanthera. Great positive news for IMM. The tide is turning for IMM. | dopey47 | |
20/9/2018 10:01 | cat - thanks, interesting interview. Seems a practical position in that, if they get it organised, 500 people on the MAP activity will give real world info'; and the 60 or so on the extension activity, reporting Q2/19 interesting if those folks and their medics wanted to continue taking. As ever its results of course but just maybe there is some reason for optimism and for sufferers maybe another treatment option eventually. Also it seems a Managed Access Program has been used by the big pharmas prior to a regulatory submission. Have a nice day. | colsmith | |
19/9/2018 15:30 | Interview on proactive investors with the bold Tim discussing the MAP programme. Im sure it will generate interesting comment on the BB hxxp://www.biotech-c | catch007 | |
19/9/2018 08:29 | For what its worth, I am glad they have finally gone public with their strategy following the p3 setbacks. I'm guessing the doctors of the 62 patients in the follow-on study along with the 500 who will hopefully join the MAP are either already seeing, or expect to see, some positive results for their patients and look forward to seeing some more news on this as it progresses. Also good to see an opportunity for progression on Nucant & Ureka which have been gathering dust for too long. I will continue to hold on to my shares and see where we are in a couple of years. It's no real biggy in the great scheme of things and I have plenty more runners in the market, its why its called speculating on the stock market, maybe I'll win, maybe I'll lose on this one but as long as you pick more winners than losers overall then that's the game. | watchman50 | |
19/9/2018 08:16 | The now lifestyle failed drug company is probably going to try another rinse and repeat placing to keep their salaries going a bit longer.Avoid, avoid, avoid. | ken chung | |
19/9/2018 08:14 | Thought I would have a look in here to see if anything constructive is being said but not too surprised to see Nobby is still regularly posting his same troll like agenda. For a supposed man of science he does seem to behave very much like, and align himself with, many of the out and out trolls that seem to have this thread on their list of regular trolling outlets (worth checking out the obvious troll's posting histories as you will find nothing constructive across a whole variety of companies). Nobby, would suggest you take a long hard look at yourself in the mirror and ask yourself if there are any PLC's that would seriously want someone like yourself around their boardroom table. You must have been a dream to work with! Are you sure you retired voluntarily or were you nudged into taking early retirement by your company at their first opportunity in order to save the frustration of your colleagues during your descent from scientist to troll? With regard to your constant 'lying Tim' monologue I see the much respected SicilianKan tried to point out to you the difference between the role of a non-executive director and an executive director but strangely you didn't have much to say about that. I also note your response on the day of the corporate update (see bottom of this post). I would be very interested to hear how & when you made your investment in Incanthera and how you plan to sell your shares given that it is not publically listed and how you failed to notice your nemesis, Tim M, is the chairman (and EXECUTIVE board member) and has been since March 2014. --------- Nobbygnome - 07 Sep 2018 - 07:19:46 - 33281 of 33543 IMMUPHARMA - IN FINAL PHASE 3 LUPUS TRIAL TARGETING BLOCKBUSTER ($1bn+) REVENUES - IMM LOL. The phrase moving the deck chairs around on the Titanic comes to mind! Sadly I am a shareholder in Incanthera and do not want that company to have anything to do with the seriously flawed IMM. And as for giving Lupuzor away for 2 years well that also sums everything up. We can't sell it so let's give it away. Great corporate strategy guys..... Note there is no mention of a deal with another Pharma. I thought there was a queue out of the car park of companies eager to sign. And now strangely they have all disappeared. Che was trumpeting this until the cows came home and how completely wrong he was. So the shambles continues unabated. The management all deserve to go and as for McCarthy well the Incanthera deal proves I wouldn't trust him as far as I could kick him! Nobby -------------------- | watchman50 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions